Two researchers at the Institute for Neurosciences (IN), a joint center of the Spanish National Research Council (CSIC) and ...
Nearly two years after announcing plans for a “real-world” academic-industrial collaboration, GE HealthCare, University of Cincinnati, UC Health, Cincinnati Children’s and JobsOhio officially opened ...
A new MRI technique developed at the University of Cambridge, Cambridge, England, could improve the detection of brain lesions responsible for focal epilepsy. The new method offers greater precision ...
Researchers have developed a new type of MRI antenna inspired by metamaterials that could reveal hard-to-image areas of the ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
UT Southwestern physicians have developed an improved targeting method, four-tract tractography, to personalize MRI-guided, high-intensity focused ultrasound (HIFU) used at UTSW to treat medication ...
Stockhead on MSN
Alterity in spotlight at medical conferences as MSA clinical research moves toward Phase III planning
Presentations at key medical conferences in May support advancement of Alterity’s lead drug ATH434 into Phase III development for Multiple ... Read More The post Alterity in spotlight at medical ...
Editor’s note: On Sept. 25, 2025, the authors retracted this article from Science after concerns were raised in 2023 about the study’s methods and data analysis. Upon reanalyzing the data, the authors ...
Over 5% of children and adolescents are diagnosed with attention deficit/hyperactivity disorder (ADHD) globally. This condition is characterized by a short attention span, hyperactivity or impulsive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results